Condition 1: Hypertension. Condition 2: Hyperuricemia. Hypertensive renal disease, Hypertensive heart and renal disease , Secondary hypertension Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease Asymptomatic hyperuricaemia
Conditions
Interventions
Intervention 1: No intervention. Intervention 2: Allopurinol a tablet (100 mg)/day,for 3 months.
Treatment - Drugs
No intervention
Allopurinol a tablet (100 mg)/day,for 3 months
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: having high level of serum uric acid (serum uric acid level greater than 6.5 mg/dl (men) or greater than 5.5 mg/dl (women). This definition was based on analyses from the Atherosclerosis Risk in Communities (ARIC) Study; Exclusion criteria: uric acid level of serum less than 6.5 for men and less than 5.5 for women, known history of allopurinol hypersensitivity or those who already were on allopurinol
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Baseline, at the beginning of each phase, each week for 3 month during each phase. Method of measurement: sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood level of uric acid. Timepoint: at the begining of study and after 3 months. Method of measurement: laboratory techniques. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Mirzamohammadi
Zanjan University of Medical Sciences
Outcome results
None listed